Hemodialysis improves endothelial venous function in end-stage renal disease

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 6, 2008, Pages 482-488

  Silva, A M V ^a,b   Signori, L U ^c   Plentz, R D M ^c   Moreno, H ^d   Barros, E ^a   Bello Klein A ^a   Schaan, Beatriz D ^c   Irigoyen, M C ^a,e  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF SANTA CRUZ DO SUL   (Brazil)

^c INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

End stage renal disease; Hemodialysis; Oxidative stress; Vascular endothelium

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBONYL DERIVATIVE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FREE RADICAL; GLUCOSE; NITRATE; NITROPRUSSIDE SODIUM; POLYSULFONE; RECOMBINANT ERYTHROPOIETIN; TRIACYLGLYCEROL;

ADULT; AGE; ANAPHYLACTOID PURPURA; ANEMIA; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS MEMBRANE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MALE; MEAN ARTERIAL PRESSURE; OXIDATIVE STRESS; REFLUX NEPHROPATHY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 54749106557     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000600008     Document Type: Article

References (28)

1. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280.
2. Zoccali C. Cardiovascular risk in uraemic patients - is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-457.
3. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 1998; 53: 1068-1077.
4. Nakanishi T, Ishigami Y, Otaki Y, Izumi M, Hiraoka K, Inoue T, et al. Impairment of vascular responses to reactive hyperemia and nitric oxide in chronic renal failure. Nephron 2002; 92: 529-535.
5. Kocak H, Ceken K, Dinckan A, Mahsereci E, Yavuz A, Yucetin L, et al. Assessment and comparison of endothelial function between dialysis and kidney transplant patients. Transplant Proc 2006; 38: 416-418.
6. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
7. Passauer J, Bussemaker E, Lassig G, Gross P. Kidney transplantation improves endothelium-dependent vasodilation in patients with endstage renal disease. Transplantation 2003; 75: 1907-1910.
8. Cross JM, Donald A, Vallance PJ, Deanfield JE, Woolfson RG, MacAllister RJ. Dialysis improves endothelial function in humans. Nephrol Dial Transplant 2001; 16: 1823-1829.
9. McGregor DO, Buttimore AL, Lynn KL, Yandle T, Nicholls MG. Effects of long and short hemodialysis on endothelial function: a short-term study. Kidney Int 2003; 63: 709-715.
10. Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis. Ital Heart J 2004; 5: 371-377.
11. Kosch M, Levers A, Barenbrock M, Matzkies F, Schaefer RM, Kisters K, et al. Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant 2001; 16: 1663-1668.
12. Miyazaki H, Matsuoka H, Itabe H, Usui M, Ueda S, Okuda S, et al. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation 2000; 101: 1002-1006.
13. Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001; 12: 2747-2752.
14. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-1138.
15. Busch M, Fleck C, Wolf G, Stein G. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? Amino Acids 2006; 30: 225-232.
16. de Sousa MG, Yugar-Toledo JC, Rubira M, Ferreira-Melo SE, Plentz R, Barbieri D, et al. Ascorbic acid improves impaired venous and arterial endothelium-dependent dilation in smokers. Acta Pharmacol Sin 2005; 26: 447-452.
17. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 1981; 11: 237-243.
18. Signori LU, Vargas da Silva AM, Della Mea Plentz R, Geloneze B, Moreno H Jr, Bello-Klein A, et al. Reduced venous endothelial responsiveness after oral lipid overload in healthy volunteers. Metabolism 2008; 57: 103-109.
19. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-363.
20. Lissi E, Pascual C, Del Castillo MD. Luminol luminescence induced by 2,2′-azo-bis(2-amidinopropane) thermolysis. Free Radic Res Commun 1992; 17: 299-311.
21. Hewitson CL, Whiting MJ, Barbara JA, Mangoni AA. Acute effects of haemodialysis on biochemical modulators of endothelial function. J Intern Med 2007; 262: 571-580.
22. Boger RH, Zoccali C. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler Suppl 2003; 4: 23-28.
23. Gutierrez LL, Mazzotti NG, Araujo AS, Klipel RB, Fernandes TR, Llesuy SF, et al. Peripheral markers of oxidative stress in chronic mercuric chloride intoxication. Braz J Med Biol Res 2006; 39: 767-772.
24. Poyrazoglu OK, Dogukan A, Yalniz M, Seckin D, Gunal AL. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients. Ren Fail 2006; 28: 723-727.
25. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16: 1189-1197.
26. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2775-2782.
27. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-1218.
28. Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47: 42-50.